World March 2, 2026

CDC Acting Director Urges Use of MMR Vaccine as U.S. Measles Cases Rise

Jay Bhattacharya emphasizes prevention and pledges federal support as the CDC coordinates response to 1,136 confirmed cases

By Nina Shah
CDC Acting Director Urges Use of MMR Vaccine as U.S. Measles Cases Rise

Acting CDC director Jay Bhattacharya reiterated that the measles-mumps-rubella (MMR) vaccine is the most dependable measure to prevent measles spread, warning that there is no cure for the disease. He said the agency is deploying resources and standing ready to provide technical staff, laboratory assistance, vaccines and therapeutics to state and local health officials upon request. The CDC reported 1,136 confirmed measles cases in the United States as of February 26, 2026. Bhattacharya, who also leads the National Institutes of Health, assumed the acting CDC directorship in February.

Key Points

  • The MMR vaccine is identified by the acting CDC director as the most reliable and effective method to prevent measles.
  • The CDC is increasing resources and coordinating regularly with state and local health officials, offering technical staff, laboratory support, vaccines and therapeutics upon request.
  • As of February 26, 2026, the CDC reported 1,136 confirmed measles cases in the United States, with Bhattacharya serving as acting CDC director since stepping into the role in February while also directing the NIH.

Acting director of the U.S. Centers for Disease Control and Prevention Jay Bhattacharya on Monday reiterated that vaccination remains the primary defense against measles, underscoring the importance of prevention in the absence of a cure.

"There is no cure for measles, which is why prevention is so critical," Bhattacharya said in a video posted on X. "The MMR vaccine remains the most reliable and effective way to prevent it."

In his remarks, Bhattacharya said the CDC is intensifying efforts to prevent transmission and to support local and state responses. He described a stepped-up allocation of agency resources and regular coordination with health officials across the country.

"We stand ready to provide CDC technical staff, laboratory support, vaccines and therapeutics upon request," he said, outlining the types of assistance the agency can offer to jurisdictions facing outbreaks or increases in case counts.

The CDC's most recent figures show 1,136 confirmed measles cases in the United States as of February 26, 2026. That tally was cited by Bhattacharya in outlining the current scale of confirmed infections within the country.

Bhattacharya, who also serves as director of the U.S. National Institutes of Health, took on the role of acting CDC director in February. In that capacity he is overseeing the agency's immediate prevention and response actions related to measles while coordinating support for public health authorities.

The acting director's comments emphasize prevention through vaccination and the federal agency's preparedness to supply personnel, laboratory capacity, vaccine doses and therapeutics when requested by local health partners. His statement highlights the CDC's active role in both technical coordination and operational support during the current period of confirmed cases.


For public health officials and health systems, the focus in the near term remains on prevention, case identification and ensuring that local providers have access to the resources they request from the CDC.

Risks

  • Measles has no cure, making prevention critical; continued transmission could increase public health burdens - impacts public health systems and healthcare providers.
  • Rising confirmed case counts may place additional demand on laboratory services and CDC technical staff requested by jurisdictions - impacts public health labs and medical laboratories.
  • Local and state health authorities may require vaccines and therapeutics from the CDC, potentially straining supply chains and distribution logistics - impacts pharmaceutical supply and healthcare delivery.

More from World

Cuba Detains 10 Panamanian Nationals Accused of Making 'Subversive' Signs Mar 2, 2026 Investigators Pursue Multiple Leads After Deadly Austin Bar Shooting; Motive Remains Unclear Mar 2, 2026 Colombia Publishes Draft to Raise Tariffs on Ecuadorian Imports to 50% Mar 2, 2026 U.S. Confirms First Combat Fatalities in Campaign Against Iran as Public Support Lags Mar 2, 2026 U.S. General Lays Out Opening Days of Military Campaign in Iran Mar 2, 2026